Related Experiment Video
Updated: Feb 8, 2026

Author Spotlight: Advancing Therapeutics to Treat Vibriosis in Humans and Aquatic Organisms
Published on: May 31, 2024
Redefining SGLT2 inhibitors through cytoprotective mechanisms
Sanja Stankovic1, Zoran Miloradovic2, Vladimir Petrovic3
1Department of Pharmacology, University of Nis School of Medicine, Nis, Serbia.
Sodium-glucose cotransporter-2 (SGLT2) inhibitors offer benefits beyond diabetes management. These drugs promote cellular health and may protect against cardiovascular and renal diseases through mechanisms independent of glucose lowering.
Area of Science:
- Pharmacology
- Cellular Metabolism
- Endocrinology
Background:
- Sodium-glucose cotransporter-2 (SGLT2) inhibitors are established type 2 diabetes treatments.
- Evidence suggests SGLT2 inhibitors have pleiotropic effects beyond glycemic control.
Purpose of the Study:
- To review the molecular mechanisms of SGLT2 inhibitors' extraglycemic actions.
- To link these mechanisms to clinical trial data and explore therapeutic repurposing.
Main Methods:
- Literature review of experimental and clinical studies.
- Analysis of cellular pathways influenced by SGLT2 inhibitors.
- Correlation of mechanistic insights with ongoing clinical trials.
Main Results:
- SGLT2 inhibitors promote ketogenesis and upregulate sirtuin 1.
- They attenuate inflammation and oxidative stress via AMPK-mTORC1 signaling.
- These actions suggest cytoprotective properties.
Conclusions:
- SGLT2 inhibitors possess extraglycemic benefits.
- These benefits may underlie their efficacy in cardiovascular and renal diseases.
- Expanded therapeutic potential beyond diabetes is indicated.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Chemical Equilibria: Redefining Equilibrium Constant
To calculate the equilibrium constants of solutions of moderately high ionic strength, one must account for the salt effect. This redefined...
Reaction Mechanisms
For instance, the decomposition of ozone appears to follow a mechanism with two steps:
Dipeptidyl Peptidase 4 Inhibitors
Mechanical Protein Functions
Antihypertensive Drugs: Direct Renin Inhibitors

